ChemChina's $43 billion takeover bid for Syngenta has received regulatory approvals from both the US and the EU.

A condition of the approvals will require ChemChina to divest crop protection assets that are owned by one of its subsidiaries, as several of the subsidiary's generic products are in direct competition with Syngenta's branded products.

Canada's Competition Bureau also approved the deal back in February.

The acquisition is expected to be finalized during the second quarter of 2017.